Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Campaigns were Conducted against the Ministry because of its Minister's Stances; some Dossiers were Excluded from the Cabinet's Agenda

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani stressed that false information has been circulated concerning the financial ceilings and the performance of the Lebanese Forces ministers was criticized, while these latter ministers have proved to be an example that should be followed in the government.  

Hasbani was quoted as saying by the state-run Tele Liban the financial prosecutor heard Tuesday two counselors who were found innocent. “We respect any judicial decision taken and the allegations and what was said about us were found to be wrong,” Hasbani added.

The financial ceilings

Hasbani explained the issue of the financial ceilings saying that in the previous years no mechanism was adopted for these ceilings which were set without clear standards. “We have adopted a mechanism based on the size of the hospital, the real number of beds, the services provided and the cost of bed. We found out that the declared number of beds in the syndicate was incorrect. The head of the association was informed and we adopted the existing number of beds in each hospital.”

“The mechanism for the financial ceilings that we have submitted to the cabinet since 2017 was not included in the agenda. Therefore, we referred to the powers stipulated in the law that give the minister the right to amend the financial ceilings as needed,” the Minister of Public Health added.

No shortage in drugs

As for drug shortages, Hasbani noted that there was no lack of free drugs in Quarantine and all what has been circulated was not true. There are many drugs of which prices were cut off according to a specific mechanism.

“The drugs available in the Lebanese markets are from all the countries and abide by all mechanisms and conditions. 25 thousand patients benefit from the drugs provided by the Ministry of Public Health,” Hasbani added.

The Ministry of Public Health conducts permanent awareness campaigns to prevent diseases. An awareness campaign on obesity will be launched soon, knowing that these campaigns receive technical and financial support from the World Health Organization and the World Bank respectively.
 
Food Safety


Hasbani tackled food safety saying that the Ministry of Public Health conducted 29 thousand inspections and issued 10 thousand warnings. “We have never heard about them in the media because they tarnish the reputation of the Lebanese food sector. We have also launched the Application “Ballegh Lel Soha” that enables the citizens to report to the ministry on any violation,” Hasbani noted
    1
ATC Name B/G Ingredients Dosage Form Price
S01ED51 XALACOM B Timolol (maleate) - 6.8mg/ml, Latanoprost - 50?g/ml Drops solution 510,660 L.L
S01EE01 XALAPROST G Latanoprost - 0.005% w/v 0.005% w/v Drops solution 421,967 L.L
S01EE01 XALATAN B Latanoprost - 50mcg/ml 50mcg/ml Drops solution 704,173 L.L
N05AX12 XALIPRO G Aripiprazole - 10mg 10mg Tablet 2,123,271 L.L
N05AX12 XALIPRO G Aripiprazole - 15mg 15mg Tablet 2,418,917 L.L
N05AX12 XALIPRO G Aripiprazole - 5mg 5mg Tablet 1,746,995 L.L
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule L.L
L01ED01 XALKORI B Crizotinib - 250mg 250mg Capsule 347,644,061 L.L
L01ED01 XALKORI B Crizotinib - 200mg 200mg Capsule 347,644,061 L.L
N05BA12 XANAX B Alprazolam - 0.5mg 0.5mg Tablet 477,064 L.L
B01AF01 XARELTO B Rivaroxaban - 2.5mg 2.5mg Tablet, film coated 4,045,168 L.L
B01AF01 XARELTO B Rivaroxaban - 15mg 15mg Tablet, film coated 4,440,862 L.L
B01AF01 XARELTO B Rivaroxaban - 20mg 20mg Tablet, film coated 4,440,862 L.L
B01AF01 XARELTO B Rivaroxaban - 10mg 10mg Tablet, film coated 1,588,892 L.L
G04CA01 XATRAL XL B Alfuzosin HCl - 10mg 10mg Tablet, prolonged release 1,061,636 L.L
B01AF01 XAVIRAN G Rivaroxaban - 15mg 15mg Tablet, film coated 952,208 L.L
B01AF01 XAVIRAN G Rivaroxaban - 20mg 20mg Tablet, film coated 952,208 L.L
B01AF01 XAVIRAN G Rivaroxaban - 10mg 10mg Tablet, film coated 606,649 L.L
L04AA29 XELJANZ B Tofacitinib - 5mg 5mg Tablet L.L
L04AA29 XELJANZ B Tofacitinib - 5mg 5mg Tablet 80,685,473 L.L
L04AA29 XELJANZ XR B Tofacitinib - 11mg 11mg Tablet, extended release 78,687,316 L.L
L01BC06 XELODA B Capecitabine - 500mg 500mg Tablet, film coated 17,946,398 L.L
D07AC13 XEMADERM G Mometasone furoate - 0.1% 0.1% Cream 335,961 L.L
A08AB01 XENICAL B Orlistat - 120mg 120mg Capsule 4,036,903 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 100 units LD50 100 units LD50 Injectable powder for solution 20,517,541 L.L
M03AX01 XEOMIN BioTech Clostridium botulinum type A neurotoxin complex - 50 units LD50 50 units LD50 Injectable powder for solution 11,920,109 L.L
J01DD15 XEVANEER G Cefdinir - 300mg 300mg Capsule 1,350,562 L.L
J01DD15 XEVANEER G Cefdinir - 125mg/5ml 125mg/5ml Powder for suspension 1,308,903 L.L
J01DD15 XEVANEER G Cefdinir - 125mg/5ml 125mg/5ml Powder for suspension 686,704 L.L
M05BX04 XGEVA BioTech Denosumab - 120mg 120mg Injectable solution 33,545,669 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026